ICON Selected by Genomics England to Support the Largest

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ICON Selected by Genomics England to Support the Largest Genome Sequencing Project of Its Kind for Cancer and Rare Diseases

DUBLIN, IRELAND--(Marketwired - Feb 25, 2016) -    ICON plc ( NASDAQ : ICLR ), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that is has been selected by Genomics England as data management partner for the 100,000 Genomes Project .

A ground-breaking project announced by the British Prime Minister David Cameron in 2012, the 100,000 Genomes Project is sequencing 100,000 whole genomes from 70,000 National Health Service (NHS) cancer and rare disease patients and their families. It aims to demonstrate a new genomic medicine service for the NHS to support better diagnosis and more personalised treatments for patients. De-identified data from the 100,000 Genomes Project will also be made available to approved researchers from the industry to help accelerate the development of new treatments and diagnostic tests that are targeted at the genetic characteristics of individual patients.

As Genomics England's data management partner, ICON will use its powerful data management capabilities, and understanding of the growing role genomics data will have in clinical trials, to validate clinical data from the 70,000 participating patients and their families. This work will take place within the secure Genomics England data environment.

" We are very proud that our genomics knowledge and our capabilities in securely managing large clinical and real world datasets have been chosen by Genomics England for such an important and transformative project," commented Professor Brendan Buckley, ICON's Chief Medical Officer. "Our partnership with Genomics England demonstrates our commitment to partnering with industry and government organisations in new and innovative ways to improve patient care by accelerating the development of targeted and personalised medicines that tackle complex diseases. Genomics England's selection of ICON also reaffirms ICON as a trusted partner to government organisations as well as the world's top pharma, biotech and medical device companies."

James Peach, Managing Director for the 100,000 Genomes Project Main Programme at Genomics England, said : "We are delighted to be partnering with ICON. Their renowned expertise in data management will be fundamental in driving scientific research and accelerating the return of results for NHS patients."

Company Logo ICON plc http://release.media-outreach.com/i/Download/4382 Genomics England http://release.media-outreach.com/i/Download/4383

About Genomics England   Genomics England is a company owned by the Department of Health and was set up to deliver the 100,000 Genomes Project. This flagship project will sequence 100,000 whole genomes from NHS patients and their families by 2017. Genomics England has four main aims:

  • To bring benefit to patients
  • To create an ethical and transparent programme based on consent
  • To enable new scientific discovery and medical insights
  • To kick-start the development of a UK genomics industry

The project is focusing on patients with rare diseases and their families, as well as patients with common cancers. More information is at www.genomicsengland.co.uk

About ICON plc ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development -- from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 89 locations in 38 countries and has approximately 11,900 employees. ICON operates from 5 locations in the UK. Further information is available at www.iconplc.com  

This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, S-8 and F-3, which are available on the SEC's website at http://www.sec.gov .

ICON Media Contact Crystal Chan +852 3511 6914 Email Contact Genomics England Media Contact Katrina Nevin-Ridley Director of Communications Genomics England +44-(0)207 882 6493 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Highway 99 Truck Death Puts Safety Records in Focus

Updated Category News Views 72

A stopped car on a highway shoulder is supposed to be a bad day, not a death sentence. Yet on November 5, 2026, a person helping a relative with a disabled vehicle was killed on northbound Highway 99 in Elk Grove after a commercial tractor-trailer allegedly drifted onto the shoulder, hit both stationary vehicles, and overturned. Northbound lanes were closed for hours. A...

Continue Reading
Leatt Sets Its Virtual 2026 Shareholder Meeting Date

Updated Category News Views 73

A calendar notice is not a catalyst, but ignoring the calendar is how shareholders miss the small moments that matter. Leatt Corporation has scheduled its 2026 virtual annual general meeting of stockholders for Friday, November 20, at 11:00 AM Eastern Time. For holders of OTCQB:LEAT, this is a basic corporate-governance event, not a new product launch or a financial...

Continue Reading
Roland DG's Brand Refresh Earns Three B2B Awards in 2026

Updated Category News Views 98

Three trophies for a printer-maker’s marketing overhaul will not move mountains by themselves, but they do tell us Roland DG has stopped treating its brand like an afterthought. The company’s global Make Your Mark refresh picked up two Silver awards and one Bronze at the 2026 Drum B2B Awards in Miami. For a business selling industrial-grade tools into crowded,...

Continue Reading
Devicie Broadens Browser Security Across Device Fleets

Updated Category News Views 57

Browsers have quietly become the front door, side door, and occasionally the busted basement window of corporate security. Devicie’s newly expanded Edge for Business Reporting Connector tackles that uncomfortable reality by pulling browser security events from Windows, macOS, iOS, and Android into the same console customers use to oversee Microsoft Intune environments....

Continue Reading
BKV Energy's $400,000 Loyalty Bet Has a Real Point Behind It

Updated Category News Views 92

Retail power customers rarely send thank-you notes; they switch plans, complain about bills, or quietly vanish. That is why BKV Energy putting more than $400,000 into its third annual ElectroShare payout deserves a harder look than the usual feel-good loyalty announcement. A Retention Expense With Some Teeth The payout has climbed quickly: roughly $113,000 in the first...

Continue Reading
MetaOptics Tests a Real Path Into Secure Imaging Markets

Updated Category News Views 77

Fingerprint scanners have never impressed me much; fooling one is exactly the sort of nuisance that keeps security buyers spending. MetaOptics’ new collaboration with Hong Kong’s ASTRI goes after that uncomfortable problem with a compact nano-optics imaging system built for biometric security and smart sensing. It is a sensible target. It is also, at this stage, a...

Continue Reading
Sinopec’s Algerian Outreach Reveals a Patient Long Game

Updated Category News Views 109

Soft Power Does Not Run a Refinery, but It Matters A short video contest in Algiers will not move an oilfield schedule or settle a hydrocarbons negotiation. That is precisely why this Sinopec-backed event deserves a sober look rather than a chest-thumping one. On Nov. 15, Sinopec Group and the Chinese Embassy in Algeria co-hosted the final of their second youth cultural...

Continue Reading
Freedom Debt Relief Earns Service Recognition in 2026

Updated Category News Views 48

A Service Badge Carries Weight in a Rough Business Debt settlement is not a business where a pleasant phone voice alone gets the job done. People arrive carrying unsecured balances, anxiety, and usually a fair amount of distrust. That is why CNBC Select naming Freedom Debt Relief its “Best for Customer Service” is more meaningful than the usual chest-thumping...

Continue Reading
Century Complete Tests Conway Demand Near Myrtle Beach

Updated Category News Views 96

Ninety-four lots in Conway may not move Wall Street by themselves, but they can say plenty about the kind of buyer Century Communities is chasing. Century Complete is opening its model at Cates Bay Crossing on Nov. 21, 2026, with single-family homes starting in the $260s. In a housing market where affordability gets talked to death and rarely delivered cleanly, that...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 87

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading

Top 5 Most Recently Viewed Articles

Jordyn Poulter Shines in Times Square After Olympic Success

Updated Category News Views 419

Jordyn Poulter Shines in Times Square After Olympic Success Attention volleyball fans and supporters of women's sports: professional women's volleyball has officially made its mark in the United States. Today, a stunning billboard featuring Olympic silver medalist Jordyn Poulter was unveiled in the bustling Times Square of New York City. Poulter previously played for UYBA...

Continue Reading
Lifecore Biomedical Plans Exciting Financial Update Soon

Updated Category News Views 260

Lifecore Biomedical Prepares to Share Financial Insights Lifecore Biomedical, Inc. (NASDAQ: LFCR) is gearing up to share its financial outcomes for the second quarter of fiscal year 2025 in early January. This exciting announcement marks a significant moment for the company, which is known for its expertise in the contract development and manufacturing landscape. What to...

Continue Reading
Peloton Interactive, Inc. Sets Earnings Call for Q1 of 2025

Updated Category News Views 86

Peloton Interactive, Inc. Earnings Call Announcement Peloton Interactive, Inc. (NASDAQ: PTON) is gearing up for an important announcement regarding its financial results. The company will share its first quarter fiscal 2025 results before the stock market opens on a Thursday in late October. This is a key moment for both the company and its investors, as it lays out the...

Continue Reading
Centerspace Boosts Core FFO Guidance Amid Market Challenges

Updated Category News Views 159

Centerspace's Successful Third Quarter Performance Centerspace (NYSE: CSR), a prominent real estate investment trust, reported a strong third quarter performance in 2024 during its recent earnings call. The company announced a core funds from operations (FFO) of $1.18 per share, reflecting a notable 3% rise in same-store revenue, alongside an improved occupancy rate of...

Continue Reading
Ammunition Depot Crowned as Leading Online Ammo Retailer

Updated Category News Views 277

Ammunition Depot Crowned as Leading Online Ammo Retailer Ammunition Depot has been recognized as the best online destination for purchasing ammunition, according to a recent feature in Guns & Ammo Magazine. This accolade highlights their dedication to delivering a remarkable customer experience complemented by fast shipping and extensive product offerings. In a detailed...

Continue Reading